Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurine eye drops for senile cataract progression
NCT06639711Phase 2Active, not recruiting
- Sponsor
- University of Anbar
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of taurine in senile cataract (ARC), sponsored by University of Anbar. Started Jul 2023; status: active, not recruiting.
02
Drugs
taurine
03
Conditions
senile cataract (ARC)
Beyond the preview
Go deeper on NCT06639711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06639711.